This HTML5 document contains 58 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n7http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58215181
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в жовтні 2011 article scientifique publié en 2011 article im Oktober 2011 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q58215181-4E7C5DA8-1321-426E-8113-9D6D4B9A0415
wdt:P577
2011-10-01T00:00:00Z
p:P2093
wds:Q58215181-9CB36F89-79F0-43E1-AB42-BF19C5C42724 wds:Q58215181-40FD907F-8DCD-43F0-822A-12ABCD0DBEF5 wds:Q58215181-EFE258A3-E3DD-4CEF-87CB-0FB68F6F62D0
wdt:P2093
Chiun Hsu Ying-Chun Shen Fu-Chang Hu
rdfs:label
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
skos:prefLabel
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
schema:name
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
p:P50
wds:Q58215181-DBD075B6-075B-495B-BD63-333D4260C6EC wds:Q58215181-A227E3DC-2ADD-4AAC-A1B5-46491C098EB0 wds:Q58215181-B5FF2BFD-3E2E-4749-BFCF-91AB1A0E7B7D wds:Q58215181-5B0DE238-EDCF-4403-88C1-CF1C2323905C wds:Q58215181-1383F705-CF28-4073-B784-8C6BFDF400AD wds:Q58215181-188CA872-6217-46E8-8F50-ADA5AA95AF98 wds:Q58215181-00EFC1AC-8F5E-41F4-918D-F72CF1F8B366
wdt:P50
wd:Q58313616 wd:Q63652323 wd:Q64226422 wd:Q117224900 wd:Q57032765 wd:Q38639483 wd:Q58313610
p:P1476
wds:Q58215181-3B951F50-CFD2-4F39-B900-10A81E841484
wdt:P1476
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
p:P304
wds:Q58215181-7D360CE2-AC3F-45A3-972C-44F661605C65
wdt:P304
858-865
p:P31
wds:Q58215181-B3EA30A7-9E29-49D9-8D0C-1AB015D0985D
wdt:P31
wd:Q13442814
p:P921
wds:Q58215181-30ECE3B5-2F66-4C28-A86E-49DA5FE10465 wds:Q58215181-CB44E714-FD2B-43EE-964B-BDE329315756 wds:Q58215181-7029561E-A549-4E29-A8CF-6C344B0766DA
wdt:P921
wd:Q181600 wd:Q864574 wd:Q1148337
p:P698
wds:Q58215181-F532FEA3-5CFA-486D-92B7-FCEBF3F6878E
wdtn:P698
n12:21338641
wdt:P698
21338641
p:P1433
wds:Q58215181-CBAADC91-6E69-402B-A5C2-2C741E9B285E
wdt:P1433
wd:Q15724402
p:P433
wds:Q58215181-E3DEA614-DAF1-4ABF-A2D9-91A05D8FE91A
p:P478
wds:Q58215181-2AAD4460-D7FA-4EA8-B95C-6BAAE42083A7
wdt:P433
4
wdt:P478
55
p:P356
wds:Q58215181-94241988-4587-49DF-A219-748067160E11
wdtn:P356
n7:J.JHEP.2011.01.032
wdt:P356
10.1016/J.JHEP.2011.01.032